ArticleMolecular medicine reports2019

Silencing RRM2 inhibits multiple myeloma by targeting the Wnt/β‑catenin signaling pathway.

Xia Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.